Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial - Raal, F J; Honarpour, N; Blom, D JTESLA Investigators (Lancet, 2015)
et al.